Study of CellCept for Advanced Pancreatic Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

October 31, 2007

Study Completion Date

January 31, 2009

Conditions
Pancreatic Cancer
Interventions
DRUG

Mycophenolate mofetil

"Dose escalation increasing successively from 1.5, 2.0, 2.5, 3.0, 3.5, 4.0, 4.5, and 5.0 grams p.o. bid.~Each patient will be treated for eight weeks (56 days)."

Trial Locations (1)

10032

Columbia University Medical Center, New York

All Listed Sponsors
lead

Columbia University

OTHER

NCT00997958 - Study of CellCept for Advanced Pancreatic Cancer | Biotech Hunter | Biotech Hunter